0,913  0,004  Eye irritation, high
0,887  0,003  GST A substrate
0,870  0,004  Skin irritative effect
0,806  0,008  TNF expression inhibitor
0,734  0,004  Ulceration
0,728  0,005  Vasodilator, peripheral
0,713  0,004  Antiglaucomic
0,722  0,014  Teratogen
0,709  0,007  Cholesterol antagonist
0,701  0,008  Sensitization
0,690  0,008  5 Hydroxytryptamine release stimulant
0,697  0,015  Embryotoxic
0,681  0,011  Respiratory analeptic
0,667  0,007  Lipoprotein disorders treatment
0,660  0,005  Antipruritic, allergic
0,649  0,014  Carcinogenic
0,661  0,029  Caspase 9 stimulant
0,641  0,010  Analeptic
0,639  0,008  Immunomodulator
0,642  0,014  Antihypercholesterolemic
0,629  0,003  Acaricide
0,621  0,005  Hypolipemic
0,621  0,009  Histamine release inhibitor
0,615  0,003  GST P1-1 substrate
0,618  0,017  Aldehyde oxidase inhibitor
0,614  0,015  Antithrombotic
0,599  0,007  Platelet antagonist
0,587  0,007  FMO1 substrate
0,581  0,009  Hypoglycemic
0,581  0,010  Antihypertensive
0,576  0,018  Atherosclerosis treatment
0,563  0,017  5 Hydroxytryptamine release inhibitor
0,559  0,014  Cardiovascular analeptic
0,549  0,006  Interleukin agonist
0,547  0,005  Skeletal muscle relaxant
0,549  0,007  Antihypertriglyceridemic
0,540  0,004  GST M1-1 substrate
0,565  0,034  Cyclophilin D inhibitor
0,565  0,034  Antidiabetic
0,544  0,016  Hepatic disorders treatment
0,538  0,021  Stroke treatment
0,525  0,008  Myocardial infarction treatment
0,531  0,016  Antiischemic
0,510  0,005  Alpha-N-acetylglucosaminidase inhibitor
0,514  0,011  Vasodilator
0,503  0,011  Antidiabetic symptomatic
0,506  0,015  Antipyretic
0,496  0,008  Muscle relaxant
0,511  0,023  GABA C receptor rho-3 antagonist
0,507  0,022  Radioprotector
0,494  0,011  Psychostimulant
0,487  0,009  Radiosensitizer
0,486  0,009  Anesthetic general
0,499  0,022  CTGF expression inhibitor
0,483  0,008  Hair growth stimulant
0,483  0,009  Antiulcerative
0,478  0,005  5 Hydroxytryptamine uptake stimulant
0,489  0,017  Vasodilator, coronary
0,480  0,012  RNA-directed DNA polymerase inhibitor
0,491  0,024  Spasmolytic
0,478  0,014  UGT2B4 substrate
0,470  0,007  Abortion inducer
0,471  0,008  Anesthetic
0,496  0,034  Immunosuppressant
0,485  0,022  Apoptosis antagonist
0,482  0,025  Cardioprotectant
0,467  0,012  Platelet aggregation inhibitor
0,458  0,005  Antipruritic, non-allergic
0,458  0,004  Antihyperlipoproteinemic
0,466  0,014  Vascular (periferal) disease treatment
0,472  0,023  Mutagenic
0,463  0,018  Cardiodepressant
0,455  0,010  Septic shock treatment
0,469  0,025  Chemoprotective
0,476  0,032  Immunostimulant
0,469  0,028  Antifungal
0,449  0,010  Hepatoprotectant
0,441  0,009  Carcinogenic, group 3
0,453  0,027  NOS3 expression inhibitor
0,504  0,086  Antiinflammatory
0,444  0,025  Interleukin antagonist
0,430  0,018  Antihypoxic
0,415  0,011  Diabetic retinopathy treatment
0,409  0,008  Protein kinase stimulant
0,407  0,006  Insulin sensitizer
0,427  0,030  UGT1A9 substrate
0,414  0,020  DNA synthesis inhibitor
0,443  0,052  CYP3A4 substrate
0,409  0,019  Sedative
0,411  0,023  Antiparasitic
0,392  0,008  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,423  0,044  Antiallergic
0,380  0,003  Toll-Like receptor 2 antagonist
0,420  0,044  Bone diseases treatment
0,402  0,028  DNA damaging
0,398  0,025  Calcium channel activator
0,401  0,029  Proliferative diseases treatment
0,377  0,005  Antihelmintic (Nematodes)
0,380  0,009  Antidote
0,381  0,012  Phospholipase C inhibitor
0,379  0,015  Antiseptic
0,362  0,005  Succinate dehydrogenase inhibitor
0,364  0,007  Aldehyde dehydrogenase inhibitor
0,361  0,005  Mediator release inhibitor
0,387  0,034  NOS2 expression inhibitor
0,361  0,008  Gastrin inhibitor
0,370  0,020  Growth hormone agonist
0,357  0,008  DNA polymerase I inhibitor
0,375  0,026  FMO3 substrate
0,356  0,008  Insulin secretagoues
0,350  0,005  Catalase inhibitor
0,368  0,025  Peroxidase inhibitor
0,364  0,021  Antiparkinsonian, rigidity relieving
0,345  0,004  Raynaud's phenomenon treatment
0,369  0,028  Angiogenesis stimulant
0,355  0,015  Tyrosine 3 hydroxylase inhibitor
0,349  0,012  Muscular dystrophy treatment
0,347  0,011  Antiparkinsonian, tremor relieving
0,371  0,037  Interleukin 2 agonist
0,363  0,031  UGT1A6 substrate
0,351  0,020  Antimutagenic
0,349  0,019  Antianginal
0,363  0,036  Cardiotonic
0,332  0,005  Adenylate kinase inhibitor
0,353  0,031  Antineoplastic (endocrine cancer)
0,336  0,023  P-glycoprotein inhibitor
0,323  0,011  Pancreatic disorders treatment
0,316  0,005  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,338  0,027  Wound healing agent
0,354  0,043  Antidiabetic (type 2)
0,330  0,021  UGT2B7 substrate
0,415  0,107  Apoptosis agonist
0,321  0,014  Sepsis treatment
0,348  0,041  Sodium/bile acid cotransporter inhibitor
0,328  0,025  Platelet adhesion inhibitor
0,314  0,012  Glutathione S-transferase substrate
0,314  0,014  Antineoplastic antimetabolite
0,315  0,016  Antiischemic, cerebral
0,310  0,011  Anesthetic local
0,322  0,024  Non-steroidal antiinflammatory agent
0,337  0,039  Amyotrophic lateral sclerosis treatment
0,303  0,005  HDL-cholesterol increasing
0,314  0,015  Bone formation stimulant
0,335  0,037  Flavin-containing monooxygenase substrate
0,335  0,038  Transcription factor STAT3 inhibitor
0,307  0,012  Phospholipase A2 inhibitor
0,302  0,007  Ferrochelatase inhibitor
0,379  0,086  Antibacterial
0,329  0,040  Heart failure treatment
0,311  0,023  VCAM1 expression inhibitor
0,332  0,046  Cytotoxic
0,360  0,074  Transcription factor NF kappa B inhibitor
0,300  0,015  Corneal wound healing stimulator
0,301  0,015  CNS active muscle relaxant
0,291  0,006  UGT2B10 substrate
0,289  0,005  Antiviral (Ebola)
0,292  0,009  Antiviral (Poxvirus)
0,288  0,006  Cyclooxygenase 3 inhibitor
0,288  0,007  Alcohol dehydrogenase substrate
0,291  0,010  GABA C receptor agonist
0,284  0,004  Antirickettsial
0,300  0,022  Antiacne
0,321  0,044  Superoxide dismutase inhibitor
0,289  0,011  Carcinogenic, group 1
0,281  0,006  Phosphofructokinase-1 inhibitor
0,294  0,021  Interferon gamma antagonist
0,301  0,030  Myocardial ischemia treatment
0,282  0,012  Antiprotozoal (Coccidial)
0,303  0,032  Antiviral (HIV)
0,276  0,006  Choleretic
0,270  0,002  Anesthetic inhalation
0,335  0,069  ICAM1 expression inhibitor
0,296  0,033  Antihelmintic
0,318  0,055  Antioxidant
0,320  0,059  Antiosteoporotic
0,310  0,050  Transcription factor STAT inhibitor
0,272  0,014  Antifungal enhancer
0,265  0,007  Calcium antagonist
0,281  0,024  Neurotrophic factor enhancer
0,268  0,012  Uterine stimulant
0,265  0,009  Antieczematic
0,262  0,008  Antispirochetal
0,288  0,035  Antihypotensive
0,286  0,033  UGT1A4 substrate
0,296  0,044  Cyclic AMP phosphodiesterase inhibitor
0,261  0,011  Excitatory amino acid transporter EAAC1 inhibitor
0,256  0,007  Glutamate dehydrogenase inhibitor
0,251  0,002  Antiviral (Parainfluenza)
0,252  0,004  Antidote, heavy metal
0,254  0,005  Arachidonic acid antagonist
0,252  0,004  GST T1-1 substrate
0,299  0,053  Tumour necrosis factor alpha release inhibitor
0,250  0,007  Triose-phosphate isomerase inhibitor
0,265  0,024  Nitric-oxide synthase stimulant
0,244  0,003  Prostaglandin agonist
0,333  0,091  Toll-Like receptor agonist
0,245  0,004  Interferon agonist
0,313  0,074  AR expression inhibitor
0,328  0,090  CYP2C9 substrate
0,243  0,007  Photosensitizer
0,249  0,014  Cathepsin H inhibitor
0,245  0,013  Cathepsin G inhibitor
0,236  0,005  Toll-Like receptor 2 agonist
0,247  0,019  Adenylate cyclase inhibitor
0,239  0,012  Microtubule formation inhibitor
0,244  0,017  Alkylator
0,254  0,029  UGT1A3 substrate
0,297  0,073  Antiepileptic
0,228  0,004  Prostaglandin F2 alpha antagonist
0,357  0,133  Antineoplastic (solid tumors)
0,281  0,057  Cytostatic
0,229  0,005  Alcohol oxidase inhibitor
0,264  0,041  Antiviral (Influenza)
0,255  0,032  Lipocortins synthesis antagonist
0,226  0,004  Paget's disease treatment
0,226  0,004  Glutamate release inhibitor
0,242  0,023  Aldehyde oxidase substrate
0,269  0,050  Anticonvulsant
0,230  0,012  Carbonic anhydrase III inhibitor
0,241  0,023  Hemostatic
0,224  0,006  Adenylate cyclase stimulant
0,235  0,019  Toll-Like receptor antagonist
0,222  0,007  Actinic keratosis treatment
0,218  0,004  Acyl-CoA dehydrogenase inhibitor
0,216  0,003  Ca2+-transporting ATPase inhibitor
0,238  0,026  Monophenol monooxygenase inhibitor
0,218  0,006  Peroxisome proliferator-activated receptor gamma agonist
0,223  0,011  Antineoplastic, alkylator
0,316  0,104  Calpain 2 inhibitor
0,246  0,034  Antiviral (Hepatitis)
0,217  0,006  Myasthenia Gravis treatment
0,230  0,020  Cell wall synthesis inhibitor
0,229  0,021  Cholesterol synthesis inhibitor
0,217  0,010  GABA C receptor antagonist
0,216  0,010  Aldehyde dehydrogenase substrate
0,235  0,030  Lipid peroxidase inhibitor
0,250  0,045  Antialcoholic
0,256  0,052  Antiarrhythmic
0,245  0,041  Antiviral (West Nile virus)
0,250  0,047  DNA methyltransferase I inhibitor
0,218  0,016  Retinoprotector
0,214  0,012  Coagulant
0,267  0,065  Antiprotozoal (Leishmania)
0,211  0,009  Antiviral (Influenza B)
0,233  0,031  Antipruritic
0,252  0,052  Chemopreventive
0,205  0,004  Acetylcholine release stimulant
0,209  0,009  TRPA1 agonist
0,213  0,014  UGT2B1 substrate
0,213  0,015  Anticataract
0,204  0,006  Prostaglandin EP2 antagonist
0,205  0,007  Carbamoyl phosphate synthetase inhibitor
0,205  0,008  Posttraumatic stress disorder treatment
0,224  0,029  UGT2B9 substrate
0,205  0,011  Vanilloid 1 agonist
0,221  0,029  Neuropathy treatment
0,215  0,024  Antiviral (Hepatitis B)
0,222  0,031  Antiviral (Hepatitis C)
0,197  0,007  Toll-Like receptor 4 antagonist
0,216  0,027  Pulmonary hypertension treatment
0,192  0,003  Lysophosphatidic acid 2 receptor antagonist
0,236  0,047  Pneumotoxic
0,241  0,053  DNA methylase inhibitor
0,197  0,010  Folate antagonist
0,268  0,082  CYP2C19 substrate
0,227  0,040  Thrombolytic
0,278  0,092  CYP2D6 substrate
0,195  0,010  Prolactin inhibitor
0,220  0,034  Melanin inhibitor
0,195  0,010  Transcription factor NF kappa B stimulant
0,205  0,020  Carcinogenic, group 2B
0,188  0,004  Elastase 1 inhibitor
0,192  0,009  GABA C receptor rho-1 antagonist
0,219  0,038  Amylase inhibitor
0,186  0,006  Antileprosy
0,198  0,019  SULT1A1 substrate
0,233  0,054  UGT1A1 substrate
0,183  0,005  Lanosterol 14 alpha demethylase inhibitor
0,211  0,035  Interleukin 6 antagonist
0,196  0,021  Expectorant
0,195  0,021  Movement disorders treatment
0,183  0,008  Glutamate decarboxylase inhibitor
0,177  0,003  Prostaglandin E2 agonist
0,178  0,006  Restless leg syndrome treatment
0,186  0,017  Contraceptive female
0,216  0,047  Diabetic nephropathy treatment
0,171  0,004  Endocannabinoid uptake inhibitor
0,187  0,021  Hearing loss treatment
0,219  0,055  CYP2B6 inhibitor
0,188  0,024  Aminopeptidase B inhibitor
0,171  0,008  UGT2B11 substrate
0,194  0,033  SULT1A3 substrate
0,260  0,098  Antipsoriatic
0,254  0,093  Insulysin inhibitor
0,163  0,002  Lysophosphatidic acid 3 receptor antagonist
0,201  0,041  Acute respiratory distress syndrome (ARDS) treatment
0,207  0,049  Antianorexic
0,201  0,044  Diuretic
0,175  0,018  Sphingosine 1-phosphate receptor 2 antagonist
0,171  0,013  Electrolyte absorption antagonist
0,161  0,004  Aconitate hydratase inhibitor
0,160  0,003  Exportin-1 inhibitor
0,162  0,006  Tourette's syndrome treatment
0,161  0,005  Oleamide hydrolase inhibitor
0,194  0,037  Catenin beta inhibitor
0,180  0,024  Growth stimulant
0,175  0,020  Mucolytic
0,163  0,008  Ornithine decarboxylase inhibitor
0,160  0,006  Glycine receptor agonist
0,172  0,018  Gastric antisecretory
0,165  0,011  Anabolic
0,180  0,027  Antiprotozoal (Amoeba)
0,245  0,093  Renal disease treatment
0,167  0,015  Selectin antagonist
0,188  0,036  GABA C receptor rho-2 antagonist
0,229  0,078  Free radical scavenger
0,195  0,045  Acetylcholine M1 receptor antagonist
0,169  0,020  Sphingosine 1-phosphate receptor 4 antagonist
0,196  0,048  Protein-tyrosine phosphatase inhibitor
0,163  0,015  Electron transport complex I inhibitor
0,165  0,017  Alcohol dehydrogenase inhibitor
0,158  0,011  Argininosuccinate synthase inhibitor
0,153  0,005  Anticholelithogenic
0,161  0,014  Thioredoxin inhibitor
0,166  0,018  Arylamine N-Acetyltransferase substrate
0,178  0,032  Antitussive
0,326  0,180  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,227  0,081  Neuropeptide Y2 antagonist
0,165  0,019  Antiviral (Papilloma)
0,174  0,029  Sphingosine 1-phosphate receptor 5 antagonist
0,168  0,024  UDP-glucose 4-epimerase inhibitor
0,146  0,003  Glucose-6-phosphate isomerase inhibitor
0,163  0,019  Carbonic anhydrase XIII inhibitor
0,185  0,042  Genotoxic
0,174  0,031  Antibacterial (Helicobacter pylori)
0,199  0,057  VEGF expression inhibitor
0,150  0,008  Sphingosine 1-phosphate receptor 4 agonist
0,153  0,012  Antiviral (Rhinovirus)
0,207  0,066  UDP-glucuronosyltransferase substrate
0,190  0,049  Antineoplastic (bone cancer)
0,144  0,005  Interferon inducer
0,173  0,034  Cell adhesion inhibitor
0,190  0,051  Prostate disorders treatment
0,143  0,004  Antimycoplasmal
0,181  0,042  Interleukin 1 antagonist
0,199  0,061  Dual specificity phosphatase 3 inhibitor
0,147  0,010  Lipase inhibitor
0,144  0,007  Peroxisome proliferator-activated receptor alpha agonist
0,162  0,025  Antiviral (CMV)
0,178  0,043  Renal failure treatment
0,143  0,009  Bile acid receptor antagonist
0,224  0,090  Calpain inhibitor
0,170  0,036  Proteasome inhibitor
0,174  0,041  Cocaine dependence treatment
0,153  0,020  Porphobilinogen synthase inhibitor
0,141  0,008  Neuraminidase (influenza) inhibitor
0,169  0,038  Antifungal (Cryptococcus)
0,141  0,010  Glycine receptor antagonist
0,168  0,037  MAP3K9 inhibitor
0,133  0,003  Prostaglandin EP4 agonist
0,167  0,037  Nav1.6 sodium channel blocker
0,153  0,023  Creatine kinase inhibitor
0,131  0,001  Lysophosphatidic acid receptor 1 agonist
0,150  0,020  Antifungal (Pneumocystis)
0,154  0,025  Caspase 3 inhibitor
0,187  0,059  Liver fibrosis treatment
0,144  0,016  Antidote, mercury
0,182  0,055  Antiviral (Herpes)
0,150  0,024  Sphingomyelinase inhibitor
0,138  0,013  Antimetabolite
0,235  0,110  Lipoxygenase inhibitor
0,287  0,163  Antiarthritic
0,142  0,019  NADH dehydrogenase inhibitor
0,131  0,008  Neuraminidase inhibitor
0,133  0,011  Ornithine carbamoyltransferase inhibitor
0,145  0,023  Antiprotozoal (Toxoplasma)
0,166  0,044  Psychosexual dysfunction treatment
0,137  0,015  Glutathione S-transferase inhibitor
0,175  0,054  UGT2B15 substrate
0,169  0,048  CF transmembrane conductance regulator agonist
0,179  0,059  ATPase inhibitor
0,119  0,001  Lysophosphatidic acid receptor 3 agonist
0,123  0,005  Squalene synthetase inhibitor
0,188  0,072  Nitric oxide antagonist
0,182  0,066  Tumour necrosis factor antagonist
0,125  0,009  Protease 3C (Human rhinovirus) inhibitor
0,129  0,014  Leukotriene antagonist
0,138  0,023  Interleukin 1 beta converting enzyme inhibitor
0,151  0,037  Menstruation disorders treatment
0,116  0,003  Prostaglandin EP2 agonist
0,120  0,007  Carbonic anhydrase XIV inhibitor
0,180  0,067  Dual specificity phosphatase inhibitor
0,156  0,044  Nav1.3 sodium channel blocker
0,127  0,015  Epoxide hydrolase inhibitor
0,118  0,006  Glutamate (mGluR6) antagonist
0,113  0,001  Carbonic anhydrase VIII inhibitor
0,113  0,001  Carbonic anhydrase X inhibitor
0,156  0,045  Antiprotozoal (Trichomonas)
0,114  0,005  Nitric oxide donor
0,134  0,025  Carbonic anhydrase VI inhibitor
0,154  0,046  Interleukin 4 antagonist
0,117  0,008  Vanilloid 4 agonist
0,123  0,015  Ribonucleoside-diphosphate reductase inhibitor
0,120  0,012  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,114  0,007  Gaucher disease treatment
0,124  0,017  Vanilloid agonist
0,126  0,020  Hematopoietic
0,207  0,101  Antineoplastic (liver cancer)
0,114  0,008  Purinergic P2Y antagonist
0,120  0,014  Biliverdin reductase inhibitor
0,117  0,011  Estrogen-related receptor beta agonist
0,167  0,061  Antiviral (Influenza A)
0,121  0,017  Ribonucleotide reductase inhibitor
0,150  0,045  Protein-tyrosine phosphatase 1B inhibitor
0,115  0,011  Beta adrenoreceptor antagonist
0,114  0,011  Peroxisome proliferator-activated receptor gamma antagonist
0,141  0,038  Xanthine oxidase inhibitor
0,118  0,016  Amidase inhibitor
0,107  0,005  Fumarate hydratase inhibitor
0,262  0,161  CYP2C19 inhibitor
0,102  0,001  Prostaglandin F2 alpha agonist
0,141  0,040  Interleukin 8 antagonist
0,137  0,037  AMP-activated protein kinase stimulant
0,110  0,010  Uterine relaxant
0,164  0,065  Cytidine deaminase inhibitor
0,118  0,020  Aminopeptidase I inhibitor
0,134  0,038  Protease inhibitor
0,149  0,054  Farnesoid X receptor antagonist
0,103  0,008  Sphingosine 1-phosphate receptor 5 agonist
0,100  0,006  Alpha-mannosidase inhibitor
0,113  0,020  Phenylalanine 4-hydroxylase inhibitor
0,105  0,012  Glycine transporter 2 inhibitor
0,100  0,008  Sphingosine 1-phosphate receptor 3 antagonist
0,111  0,020  GABA aminotransferase inhibitor
0,115  0,024  Antiprotozoal activity enhancer
0,112  0,022  Na+ K+ transporting ATPase inhibitor
0,152  0,063  Antianemic
0,103  0,013  Phospholipase D inhibitor
0,139  0,049  Beta amyloid protein antagonist
0,108  0,019  Narcotic antagonist
0,094  0,006  Mannosidase inhibitor
0,101  0,013  Acetyl-CoA transferase inhibitor
0,162  0,075  Neurotensin receptor agonist
0,101  0,014  Antidote, organophosphates
0,218  0,131  CYP1A2 substrate
0,105  0,019  Sphingosine 1-phosphate receptor antagonist
0,147  0,061  Calcium channel blocker
0,089  0,004  Geranyltranstransferase inhibitor
0,150  0,066  Neuropeptide Y1 antagonist
0,091  0,007  Adenosine deaminase inhibitor
0,161  0,079  Prostatic (benign) hyperplasia treatment
0,088  0,007  Glutamate (mGluR1a) antagonist
0,094  0,013  Potassium channel (Tandem pore domain) blocker
0,084  0,003  Prostaglandin D2 agonist
0,097  0,017  Carbonic anhydrase VB inhibitor
0,168  0,088  LDLR expression enhancer
0,194  0,114  Acute neurologic disorders treatment
0,090  0,011  Glucosylceramidase inhibitor
0,144  0,065  Pregnane X receptor agonist
0,092  0,014  Thromboxane antagonist
0,139  0,062  Skin whitener
0,083  0,006  Cholesterol esterase inhibitor
0,080  0,004  Prostacyclin agonist
0,105  0,029  Granulocyte macrophage colony stimulating factor agonist
0,082  0,007  Adenylate cyclase 1 inhibitor
0,087  0,012  Sphingosine kinase inhibitor
0,091  0,017  Glutamate (mGluR7) antagonist
0,094  0,021  GABA B receptor agonist
0,091  0,019  Human rhinovirus A protease inhibitor
0,109  0,036  Antifungal (Candida)
0,092  0,020  Maillard reaction inhibitor
0,126  0,054  Cystathionine beta-synthase inhibitor
0,084  0,013  Sphingosine 1-phosphate receptor 1 antagonist
0,110  0,039  ABCA1 expression enhancer
0,141  0,070  Heat shock protein 70 antagonist
0,187  0,117  Peptidyltransferase inhibitor
0,079  0,008  Leukotriene C antagonist
0,083  0,013  Thromboxane A2 antagonist
0,084  0,014  Leukotriene B4 antagonist
0,079  0,009  Adenine nucleotide translocase inhibitor
0,076  0,006  Membrane dipeptidase inhibitor
0,083  0,013  Antiviral (Herpesvirus 3, Human)
0,083  0,013  Calcium channel P-type blocker
0,078  0,009  Sphingosine 1-phosphate receptor agonist
0,098  0,029  CDC25A inhibitor
0,080  0,012  Thromboxane synthase inhibitor
0,073  0,005  Purinergic P2Y12 antagonist
0,075  0,008  Peroxisome proliferator-activated receptor delta agonist
0,116  0,050  Antiinfertility, female
0,083  0,017  Fatty acid synthase inhibitor
0,085  0,019  SULT2A1 substrate
0,089  0,024  NMDA receptor agonist
0,082  0,016  Potassium channel intermediate-conductance Ca-activated blocker
0,118  0,053  Antihelmintic (Fasciola)
0,126  0,061  Acetylcholine muscarinic antagonist
0,081  0,017  Beta 1 adrenoreceptor antagonist
0,146  0,082  Restenosis treatment
0,092  0,029  Calcium channel L-type blocker
0,091  0,027  Glucagon-like peptide 1 agonist
0,106  0,042  Androgen antagonist
0,082  0,019  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,072  0,009  Retinoid X receptor agonist
0,075  0,013  Acetyl-CoA transferase 2 inhibitor
0,098  0,036  Cell adhesion molecule inhibitor
0,097  0,036  Macrophage migration inhibitory factor inhibitor
0,069  0,008  Cytokine production stimulant
0,128  0,067  Cholinergic antagonist
0,088  0,028  Acetylcholine M5 receptor agonist
0,238  0,178  CYP2C9 inhibitor
0,145  0,084  Aldose reductase substrate
0,069  0,009  Sphingosine 1-phosphate receptor 1 agonist
0,074  0,014  Leukocyte elastase inhibitor
0,072  0,012  Antiviral (Hepatitis D)
0,067  0,008  Microtubule stabilization
0,120  0,061  Shock treatment
0,065  0,007  Glutamate (mGluR3) antagonist
0,063  0,005  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,067  0,009  GABA B receptor antagonist
0,071  0,013  Pregnane X receptor antagonist
0,066  0,009  Benzodiazepine antagonist
0,065  0,009  Farnesoid X receptor agonist
0,074  0,018  Lipocortins synthesis agonist
0,062  0,006  Kainate receptor agonist
0,120  0,065  Autism spectrum disorders treatment
0,088  0,033  Leukotriene synthesis inhibitor
0,102  0,048  Phosphodiesterase 6D inhibitor
0,078  0,024  Cathepsin E inhibitor
0,077  0,023  MDM2 inhibitor
0,090  0,036  Histidine decarboxylase inhibitor
0,138  0,084  Antidiabetic (type 1)
0,057  0,003  Toll-Like receptor 4 agonist
0,081  0,028  Antiemphysemic
0,058  0,005  Cholesterol ester transfer protein antagonist
0,097  0,043  Tocolytic
0,089  0,036  NAT1 substrate
0,057  0,004  Elastase 2 inhibitor
0,057  0,004  Elastase 2A inhibitor
0,086  0,033  Carbonic anhydrase VA inhibitor
0,056  0,003  Calcium-independent phospholipase A2 inhibitor
0,091  0,039  Antibiotic
0,061  0,009  Antiviral (Enterovirus)
0,120  0,070  Acetylcholine antagonist
0,069  0,019  Ryanodine receptor antagonist
0,054  0,004  Elastase 3B inhibitor
0,054  0,004  Elastase 2B inhibitor
0,054  0,004  Elastase 3A inhibitor
0,091  0,041  Caspase 7 inhibitor
0,068  0,018  Beta 2 adrenoreceptor antagonist
0,066  0,017  HCV NS3/NS4A protease inhibitor
0,053  0,004  Lysophosphatidic acid 1 receptor antagonist
0,188  0,138  Antineoplastic (pancreatic cancer)
0,106  0,057  Sulfotransferase substrate
0,095  0,046  Antiviral (Hepatitis A)
0,057  0,008  Peroxisome proliferator-activated receptor delta antagonist
0,206  0,157  Thyroid hormone antagonist
0,065  0,017  Carbonic anhydrase VII inhibitor
0,053  0,006  HMG CoA reductase inhibitor
0,057  0,009  Angiotensin AT1 receptor antagonist
0,060  0,013  G protein-coupled receptor agonist
0,087  0,040  Keratolytic
0,053  0,007  ATP citrate lysase inhibitor
0,054  0,008  Leukotriene C4 antagonist
0,064  0,019  Vanilloid 2 antagonist
0,113  0,068  Sphingosine 1-phosphate receptor 2 agonist
0,125  0,080  Liver cirrhosis treatment
0,142  0,098  Cystic fibrosis treatment
0,056  0,012  Arginase inhibitor
0,107  0,063  DOPA decarboxylase inhibitor
0,048  0,004  Toll-Like receptor 8 agonist
0,056  0,012  Phosphoglycerate kinase inhibitor
0,058  0,016  5-Alpha-reductase inhibitor
0,136  0,094  Anticoagulant
0,050  0,008  Peroxisome proliferator-activated receptor alpha antagonist
0,078  0,037  Carbonic anhydrase V inhibitor
0,054  0,013  Acetyl-CoA transferase 1 inhibitor
0,132  0,092  Thiol protease inhibitor
0,197  0,157  Thyroid hormone beta antagonist
0,042  0,002  Carbonic anhydrase XI inhibitor
0,069  0,029  Corticotropin releasing factor 2 receptor antagonist
0,043  0,004  Vanilloid 2 agonist
0,065  0,026  Sphingosine kinase 2 inhibitor
0,071  0,031  Purinergic P2X1 antagonist
0,041  0,004  Calcium-dependent phospholipase A2 inhibitor
0,081  0,043  SULT1A2 substrate
0,046  0,009  Angiotensin II receptor antagonist
0,085  0,048  Chymotrypsin inhibitor
0,049  0,012  Glutamate (mGluR8) agonist
0,046  0,009  Uridine phosphorylase inhibitor
0,052  0,015  Sphingosine kinase 1 inhibitor
0,100  0,063  Chronic obstructive bronchitis treatment
0,040  0,003  Isoleucine-tRNA ligase inhibitor
0,047  0,011  Sodium-dependent vitamin C transporter 2 inhibitor
0,060  0,025  Phosphorylase inhibitor
0,048  0,012  Cholesterol absorption inhibitor
0,049  0,014  Glucagon-like peptide 1 receptor antagonist
0,058  0,023  Squalene epoxidase inhibitor
0,048  0,014  Prostacyclin antagonist
0,090  0,056  ATPase (Vacuolar H+) inhibitor
0,070  0,037  NMDA receptor glycine site agonist
0,056  0,023  Aldosterone antagonist
0,119  0,086  Antihelmintic (Trematoda)
0,053  0,020  Neuraminidase (Influenza A) inhibitor
0,035  0,003  Thromboxane A2 agonist
0,059  0,027  Immunoglobulin Fc receptor antagonist
0,182  0,150  Antineurogenic pain
0,098  0,066  Bronchodilator
0,068  0,037  Beta 3 adrenoreceptor antagonist
0,094  0,064  Interleukin 12 antagonist
0,037  0,006  Glutamate (mGluR1) agonist
0,087  0,056  Carcinogenic, group 2A
0,034  0,004  Neuraminidase (Influenza B) inhibitor
0,082  0,052  Acetylcholine nicotinic antagonist
0,047  0,017  Calcitonin receptor agonist
0,040  0,011  Epoxide hydrolase 1 inhibitor
0,041  0,012  Hypoxanthine phosphoribosyltransferase inhibitor
0,035  0,006  Hedgehog signaling activator
0,037  0,009  Purinergic P2Y15 antagonist
0,031  0,003  Thromboxane agonist
0,064  0,036  Androgen agonist
0,055  0,027  CD45 antagonist
0,065  0,038  Caspase 9 inhibitor
0,147  0,120  Toxic, respiratory center
0,043  0,016  Vanilloid 3 antagonist
0,061  0,033  Acetylcholine muscarinic agonist
0,040  0,013  Carboxypeptidase B inhibitor
0,049  0,022  Guanylate cyclase inhibitor
0,040  0,014  Peptide deformylase inhibitor
0,059  0,033  Matrix metalloproteinase (membrane-type) inhibitor
0,130  0,104  Hexokinase inhibitor
0,038  0,013  Leukotriene B4 receptor 1 antagonist
0,069  0,045  Matrix metalloproteinase inhibitor
0,037  0,012  Prostaglandin EP4 antagonist
0,045  0,020  GABA uptake inhibitor
0,038  0,014  Methionyl aminopeptidase 1 inhibitor
0,074  0,050  Metalloproteinase-9 inhibitor
0,104  0,081  Neutropenia treatment
0,048  0,025  AICAR transformylase inhibitor
0,035  0,013  Lysine carboxypeptidase inhibitor
0,079  0,058  Antineoplastic antibiotic
0,056  0,034  Prostaglandin antagonist
0,036  0,014  Glutamate (mGluR3) agonist
0,060  0,038  Botulinum neurotoxin type A inhibitor
0,061  0,039  Carbonic anhydrase stimulant
0,053  0,032  Prolyl endopeptidase inhibitor
0,026  0,006  Ileal bile acid transport inhibitor
0,088  0,068  Antischistosomal
0,025  0,004  Vitamin D receptor agonist
0,077  0,056  Metalloproteinase-2 inhibitor
0,051  0,031  Plasminogen activator inhibitor antagonist
0,054  0,034  Autotaxin inhibitor
0,037  0,018  Benzodiazepine receptor peripheral-type antagonist
0,098  0,079  GABA receptor agonist
0,026  0,007  Excitatory amino acid transporter 3 inhibitor
0,030  0,012  Purinergic P2T antagonist
0,030  0,012  Glucosylceramidase stimulant
0,030  0,012  Thyroid hormone agonist
0,105  0,088  Mental retardation treatment
0,092  0,075  Nitric-oxide synthase inhibitor
0,022  0,006  Methylmalonyl-CoA mutase inhibitor
0,146  0,129  Phobic disorders treatment
0,058  0,042  VEGFR2 expression inhibitor
0,111  0,095  Gastritis treatment
0,053  0,037  Elastase inhibitor
0,059  0,044  Cannabinoid CB1 receptor agonist
0,184  0,169  12-Lipoxygenase inhibitor
0,111  0,095  Nav1.2 sodium channel blocker
0,049  0,034  Bombesin 2 receptor antagonist
0,053  0,038  Heparanase inhibitor
0,039  0,024  Retinoid X receptor antagonist
0,114  0,099  Histone deacetylase SIRT1 inhibitor
0,053  0,039  Cathepsin D inhibitor
0,049  0,034  Metalloproteinase-3 inhibitor
0,054  0,040  Angiotensin-converting enzyme inhibitor
0,165  0,152  5 Hydroxytryptamine 3E antagonist
0,092  0,079  Falcipain 3 inhibitor
0,027  0,014  Acid ceramidase inhibitor
0,045  0,031  Fructose-1,6-bisphosphatase inhibitor
0,022  0,009  Caspase 8 inhibitor
0,036  0,023  Ceramide glucosyltransferase inhibitor
0,020  0,007  Telomerase stimulant
0,080  0,068  D-Ala-D-Ala ligase inhibitor
0,184  0,172  Hypoxia-inducible factor 1 alpha inhibitor
0,028  0,016  Leukotriene D4 antagonist
0,081  0,070  Interleukin 5 antagonist
0,115  0,103  Neurotrophic factor
0,040  0,028  Dopamine D5 agonist
0,028  0,017  Kynurenine 3 monooxygenase inhibitor
0,070  0,059  S-adenosyl-L-methionine decarboxylase inhibitor
0,032  0,021  Caspase 2 inhibitor
0,076  0,066  ErbB-3 antagonist
0,021  0,011  Apical sodium codependent bile acid transporter inhibitor
0,022  0,012  Retinoid X beta receptor antagonist
0,027  0,017  Nicotinic acid receptor 2 antagonist
0,018  0,008  Purinergic P2Y1 agonist
0,025  0,016  Sodium/glucose cotransporter 1 inhibitor
0,041  0,031  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,035  0,026  Nicotinic acid receptor agonist
0,039  0,031  Thymidine kinase inhibitor
0,030  0,021  Acetylcholine M4 receptor agonist
0,033  0,025  Retinoid X alpha receptor antagonist
0,097  0,089  Calcium channel (voltage-sensitive) blocker
0,020  0,012  Antibiotic Anthracycline-like
0,041  0,033  Macrophage elastase inhibitor
0,057  0,049  Narcolepsy treatment
0,049  0,041  Protein 50S ribosomal subunit inhibitor
0,016  0,008  Angiotensin AT1B receptor antagonist
0,025  0,018  Prostaglandin H2 antagonist
0,052  0,045  Epithelial sodium channel blocker
0,039  0,034  Hypogonadism treatment
0,032  0,026  Sphingosine 1-phosphate receptor 3 agonist
0,108  0,102  DNA repair enzyme inhibitor
0,055  0,049  Acetylcholine M2 receptor antagonist
0,017  0,013  Aminopeptidase A inhibitor
0,034  0,029  Glutamate (mGluR8) antagonist
0,017  0,012  G-protein-coupled receptor 120 agonist
0,014  0,010  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,032  0,028  Glucose-dependent insulinotropic receptor agonist
0,038  0,035  Plasmepsin II inhibitor
0,032  0,028  Retinoid X alpha receptor agonist
0,067  0,064  CYP2A6 inhibitor
0,027  0,024  Prostaglandin EP3 antagonist
0,150  0,147  Antiamyloidogenic
0,047  0,044  Neuropeptide agonist
0,023  0,020  Excitatory amino acid transporter 2 inhibitor
0,034  0,031  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,021  0,018  Angiotensin AT1A receptor antagonist
0,057  0,055  Neutrophil collagenase inhibitor
0,032  0,029  Renin inhibitor
0,106  0,104  Cytokine production inhibitor
0,010  0,008  Angiotensin AT2 receptor agonist
0,074  0,072  Inducible nitric-oxide synthase inhibitor
0,037  0,035  Oxytocin agonist
0,048  0,046  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,029  0,027  Sirtuin 2 inhibitor
0,007  0,005  DNA polymerase III subunit alpha inhibitor
0,051  0,050  Postcoital contraceptive
0,020  0,019  Glutamate (mGluR1a) agonist
0,018  0,017  Angiotensin AT2 receptor antagonist
0,020  0,020  Vitamin D receptor antagonist

